PR-619, a General Inhibitor of Deubiquitylating Enzymes, Diminishes Cisplatin Resistance in Urothelial Carcinoma Cells through the Suppression of c-Myc: An In Vitro and In Vivo Study
Fu-Shun Hsu(National Taiwan University), Kuo‐How Huang(National Taiwan University), Kuan-Lin Kuo(National Taiwan University), Shao-Ping Yang(National Taiwan University Hospital), Yen‐Ling Chiu(Johns Hopkins Medicine), Jun-Ren Dong(National Taiwan University Hospital), Wei‐Chou Lin(National Taiwan University), Shing‐Hwa Liu(National Taiwan University), Yueh-Tang Chen(National Taiwan University Hospital), Shih-Ming Liao(National Taiwan University Hospital), Ruei-Je Chang(National Taiwan University Hospital), Shih-Chen Chang(National Taiwan University Hospital), Chen-Hsun Hsu(National Taiwan University Hospital)
Cited by 27
Related Papers
The MicroRNA Spectrum in 12 Body Fluids
|Clinical Chemistry|2010|2.8k
New advances in CMV and immunosenescence
|Experimental Gerontology|2014|149
Aristolochic acid‐induced upper tract urothelial carcinoma in Taiwan: Clinical characteristics and outcomes
|International Journal of Cancer|2013|133
Kidney impairment in primary aldosteronism
|Clinica Chimica Acta|2011|133